U.S. markets close in 4 hours 58 minutes

Ligand Pharmaceuticals Incorporated (LGND)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
154.61+1.75 (+1.14%)
As of 11:02AM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Fast Stochastic

Fast Stochastic

Previous Close152.86
Open154.38
Bid151.29 x 900
Ask152.01 x 1000
Day's Range148.08 - 154.61
52 Week Range57.24 - 219.75
Volume67,247
Avg. Volume648,081
Market Cap2.568B
Beta (5Y Monthly)1.27
PE Ratio (TTM)N/A
EPS (TTM)-0.18
Earnings DateMay 04, 2021 - May 10, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateJul 02, 2010
1y Target Est224.67
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Here Are The Stocks With The Highest Short Interest Rate
    Benzinga

    Here Are The Stocks With The Highest Short Interest Rate

    Short interest rates can be used to predict the potential direction of an individual stock. When stocks have a high short interest rate that's a good indicator that investors believe their share prices will decline soon. Here are the stocks on the market with the highest short interest including Tanger Factory Outlet Centers, Ligand Pharmaceuticals, Macerich, Mallinckrodt PLC, and Briggs & Stratton Corp. 1. Ligand Pharmaceuticals Inc- 62.24% Ligand Pharmaceuticals (NYSE: LGND) is a biopharmaceutical company that develops and acquires technologies to benefit pharmaceutical companies. Their primary focus is on drug discovery, early-stage drug development, product reformulation, and partnering. Ligand Pharmaceuticals has consistently had one of the highest short interest percentages of any biotech on the stock market. 2. Macerich Co- 52.55% Macerich Co (NYSE: MAC) is a real investment trust company that invests in shopping centers across the United States. Macerich owns interest in 52 properties and is one of the country's leading owners, operators, and developers of major retail real estate. Macerich recently announced a quarterly cash dividend of 15 cents per share that will be paid out on March 3th 3. Mallinckrodt PLC- 50.77% Mallinckrodt Pharmaceuticals (NYSE: MNKKQ) focuses on developing innovative therapies and cutting-edge technologies for critical health conditions. They offer advanced medical solutions to better serve all of their patients and dedicated customers. In 2020 shares of the stock dropped after the company announced it had filed for Chapter 11 Bankruptcy. 4. Tanger Factory Outlet Centers, Inc - 50.56% Tanger Factory Outlet Centers (NYSE: SKT) is a real estate investment trust that targets shopping centers that have outlet centers. They own and operate 37 open-air outlet centers in the United States and Canada. Tanger reported strong fourth quarter earnings and the stock has risen by up to 75% this year. 5. Briggs & Stratton Corp- 45.81% Briggs & Stratton Corp (NYSE: BGGSQ) is an American Fortune 1000 manufacturer of gasoline engines. They produce gasoline engines, lawn equipment, and commercial engines for companies across the world. Briggs & Stratton Corp anticipates a full-year sales growth of approximately 3.5% which is down from last year. If you are new to investing, you should consider consulting a financial advisor to help you with your investment strategy. See more from BenzingaClick here for options trades from BenzingaLet's Take A Look At This Weeks Top-Performing SectorsHow Much Would You Have Made If You Invested 00 In Walmart 10 Years Ago?© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • Co-Diagnostics Clears Technical Benchmark, Hitting 90-Plus RS Rating
    Investor's Business Daily

    Co-Diagnostics Clears Technical Benchmark, Hitting 90-Plus RS Rating

    Co-Diagnostics saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, with an upgrade from 87 to 92. Co-Diagnostics is now considered extended and out of buy range after clearing a 6.34 buy point in a first-stage cup without handle. Co-Diagnostics earns the No. 32 rank among its peers in the Medical-Biomed/Biotech industry group.

  • Stocks Reverse Lower, Seek To Rebound; Cannabis Stocks Routed
    Investor's Business Daily

    Stocks Reverse Lower, Seek To Rebound; Cannabis Stocks Routed

    The stock market started fading at midday Thursday, as some of the market's hottest stocks sold off. The IBD 50, though, held up.